Satori Pharmaceuticals Shuts Down After Alzheimer Trial Failure

Published: May 31, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cambridge, MA-based Satori Pharmaceuticals has abruptly shut down due to issues with preclinical studies on its experimental treatment for Alzheimer’s disease.

Help employers find you! Check out all the jobs and post your resume.

Back to news